⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Class Action Alert: Levi & Korsinsky Reminds MoonLake (MLTX) Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX FRAUD NOTICE: MoonLake Immunotherapeutics Has Been Sued For Securities Fraud - Investors Are Notified to Contact BFA Law Before Upcoming December 15 Deadline
accessnewswire.com
MLTX
Class Action Lawsuit Filed: MoonLake Immunotherapeutics (MLTX) - Join by December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025
accessnewswire.com
MLTX
SueWallSt Podcast Update: Levi & Korsinsky Details MLTX Class Action Claims
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
globenewswire.com
MLTX